Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), today announced that Michael Roshon, MD, PhD, Chief of Staff at Penrose-St. Francis Hospital in Colorado Springs, Colorado, who served as Principal Investigator of the just completed Phase I trial of intravenous Ampion
September 14, 2020
· 2 min read